Cargando…
Loss of FBXO7 results in a Parkinson's‐like dopaminergic degeneration via an RPL23–MDM2–TP53 pathway
The field of Parkinson's disease research has been impeded by the absence of animal models that clearly phenocopy the features of this neurodegenerative condition. Mutations in FBXO7/PARK15 are associated with both sporadic Parkinson's disease and a severe form of autosomal recessive early...
Autores principales: | Stott, Simon RW, Randle, Suzanne J, Al Rawi, Sara, Rowicka, Paulina A, Harris, Rebecca, Mason, Bethany, Xia, Jing, Dalley, Jeffrey W, Barker, Roger A, Laman, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790581/ https://www.ncbi.nlm.nih.gov/pubmed/31144295 http://dx.doi.org/10.1002/path.5312 |
Ejemplares similares
-
Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins
por: Nelson, David E., et al.
Publicado: (2013) -
Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells
por: Harris, Rebecca, et al.
Publicado: (2021) -
Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27
por: Patel, Shachi P., et al.
Publicado: (2016) -
The important role of MDM2, RPL5, and TP53 in mycophenolic acid-induced cleft lip and palate
por: Lin, Yangyang, et al.
Publicado: (2021) -
Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression
por: Randle, Suzanne J, et al.
Publicado: (2015)